Search for: "Par, Inc."
Results 741 - 760
of 1,121
Sort by Relevance
|
Sort by Date
11 Apr 2013, 4:57 am
FTC Sues Regarding AndroGel Patent SettlementThe Federal Trade Commission has filed a complaint in federal district court challenging agreements in which Solvay Pharmaceuticals, Inc. paid generic drug makers Watson Pharmaceuticals, Inc. and Par Pharmaceutical Companies, Inc. to delay generic competition to Solvay’s branded testosterone-replacement drug AndroGel, a prescription pharmaceutical with annual sales of more than $400 million. [read post]
2 Apr 2013, 2:48 pm
Last month, Par Pharmaceutical Companies Inc. pleaded guilty to federal criminal charges and agreed to settle civil allegations involving the company’s promotion of the drug Megace ES. [read post]
2 Apr 2013, 1:55 pm
Last month, Par Pharmaceutical Companies Inc. pleaded guilty to federal criminal charges and agreed to settle civil allegations involving the company’s promotion of the drug Megace ES. [read post]
1 Apr 2013, 7:36 am
Inc. c. [read post]
1 Apr 2013, 7:36 am
Inc. c. [read post]
20 Mar 2013, 4:00 am
Atelier Granite nature inc. 2012 QCCQ 14195 [1] Madame Paré et monsieur Robitaille réclament 7 000 $ à Atelier Granite nature inc. [read post]
15 Mar 2013, 6:22 am
SandRidge Energy, Inc., C.A. [read post]
13 Mar 2013, 11:50 am
Citigroup, Inc., No. 10-0722-cv(L) and 10-0867-cv(CON), 2013 WL 791397 (2d Cir. [read post]
13 Mar 2013, 11:50 am
Citigroup, Inc., No. 10-0722-cv(L) and 10-0867-cv(CON), 2013 WL 791397 (2d Cir. [read post]
13 Mar 2013, 6:47 am
Manitoba Metis Federation Inc. v. [read post]
13 Mar 2013, 4:45 am
Companies Agree to Sell Rights to 18 Drugs to Satisfy FTCThe Federal Trade Commission will require Watson Pharmaceuticals, Inc. and Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz International GmbH and Par Pharmaceuticals, Inc, and relinquish the manufacturing and marketing rights to three others, to settle charges that Watson’s proposed $5.9 billion acquisition of Actavis would otherwise be anticompetitive.... [read post]
11 Mar 2013, 8:12 am
New Jersey-based Par Pharmaceutical Companies Inc. [read post]
7 Mar 2013, 10:34 pm
Motorola, Inc. [read post]
5 Mar 2013, 1:56 am
On March 5, the Department of Justice announced that generic drug maker Par Pharmaceuticals, Inc., entered a guilty plea and agreed to pay a combined $45 million to settle criminal and civil charges that it promoted Megace ES off-label. [read post]
27 Feb 2013, 9:41 pm
Actavis Inc. et al. [read post]
15 Feb 2013, 9:13 am
AMFs problems of the late 1970s continued into the 1980s when Minstar, Inc. acquired it in a hostile takeover. [read post]
12 Feb 2013, 10:13 am
Hammond, IN - Unverferth Manufacturing Company, Inc. of Kalida, OH has filed suit against Par-Kan Company of Silver Lake, IN for the infringement of United States Patent No. 8,221,047, which has been registered by the USPTO. [read post]
11 Feb 2013, 6:00 am
Of course self-insured employers do not set out to get sub-par results from the adjusters. [read post]
9 Feb 2013, 4:04 pm
., 6 November 2003FranceRecommendations of the French NCP to EDF and its partners regarding the “Nam Theun 2” Project in Laos / Recommandations du PCN français à l'intention de l'entreprise EDF et de ses partenaires au sujet de la mise en œuvre du projet "Nam Theun 2" au Laos, 26 May 2005 Public statement by the French NCP concerning ASPOCOMP / Communiqué publié par le PCN français concernant ASPOCOMP, 13 November… [read post]
7 Feb 2013, 10:50 am
Par Pharmaceutical, Inc., 694 F.3d 1344, 1351 (Fed. [read post]
